hydroxychloroquine has been researched along with codeine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
MASON, RM | 1 |
MCDUFFIE, FC | 1 |
González, NS; Kechida, M; Lorenzo, N; Ortiz, MBA; Parodis, Y; Perez, JCR | 1 |
1 review(s) available for hydroxychloroquine and codeine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for hydroxychloroquine and codeine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
USE OF DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Codeine; Humans; Hydroxychloroquine; Methadone; Morphine; Oxyphenbutazone; Phenylbutazone; Toxicology | 1964 |
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marrow Diseases; Codeine; Depression; Dextropropoxyphene; Drug Hypersensitivity; Drug Therapy; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methenamine; Prednisolone; Salicylates; Sulfonamides; Toxicology | 1965 |
Thrombotic thrombocytopenic purpura in a new onset lupus patient?
Topics: Adult; Anemia, Hemolytic; Autoantibodies; Blood Platelets; Codeine; Cyclophosphamide; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Remission Induction; Rituximab; Sjogren's Syndrome | 2017 |